NASDAQ · Medical - Healthcare Plans

CLOV (CLOV) Stock

$4.76 +2.15% NASDAQ: CLOV Healthcare

Valuation

MetricValue
Price$4.76
Market Cap$2.47B
P/E Ratio48.35
P/B Ratio7.48
P/S Ratio1.13
EPS (TTM)$0.00
52-Week High$5.53
52-Week Low$1.58
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.86%
ROA-5.55%
ROCE-27.83%
Gross Margin18.39%
Operating Margin-2.57%
Net Margin-2.58%
Debt/Equity0.00
Current Ratio1.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.5B$1.1B$1.3B$1.4B$1.9B
Operating Profit$-637.0M$-287.0M$-205.0M$-46.0M$-86.0M
Net Profit$-588.0M$-340.0M$-213.0M$-43.0M$-86.0M
EPS$-1.25$-0.71$-0.45$-0.09$-0.17
Op Margin-43.3%-26.1%-16.3%-3.3%-4.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$951.0M$809.0M$571.0M$581.0M$541.0M
Total Liabilities$411.0M$452.0M$284.0M$240.0M$232.0M
Cash$300.0M$104.0M$116.0M$195.0M$78.0M
Borrowings$28.0M$6.0M$5.0M$0$0

Latest News

Clover Health Investments (CLOV) Faces A Valuation Test Ahead Of August Earnings Simply Wall St. · Jul 11, 2026 Is Clover Health Investments (CLOV) Reasonable After Its 3.8x Run? Simply Wall St. · Jul 10, 2026 Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 9, 2026 Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up GlobeNewswire · Jul 7, 2026 Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors. Motley Fool · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-282.0M$-204.0M$-116.0M$35.0M$-67.0M
Investing Cash Flow$-436.0M$91.0M$139.0M$-1.0M$2.0M
Financing Cash Flow$666.0M$-6.0M$-35.0M$-18.0M$-55.0M
Net Cash Flow$208.0M$-114.0M$-10.0M$18.0M$-116.0M
Free Cash Flow$-283.0M$-208.0M$-116.0M$33.0M$-69.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-40.36
FCF Yield2.18%
Quick Ratio1.33
Interest Coverage—
Return 1Y45.03%
Return 3Y299.15%
Return 5Y-41.99%

Ownership

Insiders Held4.40%
Institutions Held29.98%
Institutions Float Held31.36%
Institutional HolderSharesReport Date
Blackrock Inc.31,840,5122026-03-31
Vanguard Capital Management LLC16,982,0732026-03-31
Geode Capital Management, LLC10,055,5102026-03-31
State Street Corporation9,559,8892026-03-31
Charles Schwab Investment Management, Inc.5,300,4752026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BGMBGM Group Ltd. $0.30 +0.10% -1.81 $59.46M 0.00%
CERT $8.18 +0.99% -467.00 $1.27B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%
GRDN $43.83 +11.05% 45.92 $2.78B 0.00%
LFST $10.54 +0.57% 390.00 $4.09B 0.00%

About CLOV

CLOV stock trades at $4.76 with a market capitalization of $2.47B. The stock is valued at a price-to-earnings (P/E) ratio of 48.35, price-to-book of 7.48, price-to-sales of 1.13. Over the past 52 weeks the stock has ranged between $1.58 and $5.53, and currently trades 13.9% below its 52-week high.

On profitability, CLOV generates a return on equity (ROE) of -16.86%, return on capital employed of -27.83%, an operating margin of -2.57%, a net profit margin of -2.58%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides